Here are three of the most important developments in Parkinson’s disease from January 2026.
1. A Simple Eye Test Could Track Your Parkinson’s—From Your Own Home
NeuraLight just completed a major trial using webcam eye-tracking to measure Parkinson’s.
No clinic visits. Just look at a camera for a few minutes.
What this means for you: Right now, you wait months between doctor appointments to see if your treatment is working.
This eye test changes that:
- Takes minutes at home
- Tracks your Parkinson’s more accurately than current tests
- Shows if your medication is helping—in real time
- Your doctor can adjust treatment faster
The benefit: Instead of wondering for months if your medication is working, you get answers right away.
More control over your care. Better treatment decisions. Less time in waiting rooms.
Soon, tracking your Parkinson’s could be as simple as a video call—giving you and your doctor the answers you need, when you need them.
2. Scientists Just Found How Parkinson’s Spreads—And How to Stop It
Yale researchers discovered two proteins that act like doorways, letting toxic Parkinson’s protein spread from brain cell to brain cell.
When they blocked these proteins in mice, the toxic protein couldn’t spread. No spread meant no Parkinson’s symptoms.
What this means for you: Right now, your medications only manage symptoms like tremors and stiffness. They don’t stop Parkinson’s from getting worse over time.
This discovery changes the game.
These two proteins are brand new drug targets. If scientists can block them in humans as they did in mice, they could:
- Stop Parkinson’s from spreading to new brain cells
- Slow or halt disease progression
- Preserve the brain function you still have
This won’t change your treatment today, but it’s a major step toward drugs that actually stop the disease—not just mask the symptoms.
For the first time, stopping Parkinson’s at its source might actually be possible.
3. New Drug Trial Could Slow Parkinson’s for People Just Starting Treatment
BioVie just finished enrolling patients in a trial testing bezisterim—a drug that might actually slow down Parkinson’s, not just treat symptoms.
Why this matters: Most Parkinson’s drugs only help with tremors and stiffness. They don’t stop the disease from getting worse.
Bezisterim targets brain inflammation—one of the main things that makes Parkinson’s progress.
In earlier trials, people taking it had better motor control and fewer side effects.
What this means for you: If you were recently diagnosed, drugs like this could one day slow how fast your Parkinson’s progresses—not just cover up the symptoms. Results come out mid-2026.
The future isn’t just managing Parkinson’s—it’s slowing it down from the start.